Role of nitric oxide in omeprazole protection of the gastric mucosa in rats.
LE Qiao-liang, Jie Zhang, Qi-zeng Xu, He-Yuan Gao
Abstract
LE Qiao-liang, Jie Zhang, Qi-zeng Xu, He-Yuan Gao
Abstract
OBJECTIVE: To understand the role of nitric oxide in the protection mechanism for the gastric mucosa in rats provided by omeprazole. METHODS: Intravenous injections with omeprazole, N -nitro-L-arginine methyl ester (L-NAME), L-arginine, or D-arginine were administered in rats with gastric mucosal lesion induced by pure ethanol. Gastric mucosal blood flow (GMBF), pH of the gastric juice and gastric mucosal NO 2 /NO 3 ratio were determined and the changes of ulcer index and the severity of tissue necrosis and neutrophil infiltration observed. RESULTS: The ulcer index of rats with omeprazole treatment was much lower than that of the control group (P<0.01) with lesser degree of tissue necrosis and neutrophil infiltration (P<0.01). The protective effect of omeprazole was significantly inhibited by prior administration of L-NAME that, however, was antagonized by prior administration of L-arginine, but not D-arginine. Intravenous omeprazole administration obviously increased GMBF and gastric mucosal NO-2 /NO 3 ratio, and such effect, apart from its action against secretion, could be counteracted by pretreatment with L-NAME. CONCLUSION: Omeprazole can exert important protection against gastric mucosal lesion in rats mediated by nitric oxide, and the action of omeprazole against gastric acid secretion contributes little to the protective effect.
OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To understand the role of nitric oxide in the protection mechanism for the gastric mucosa in rats provided by omeprazole. METHODS: Intravenous injections with omeprazole, N -nitro-L-arginine methyl ester (L-NAME), L-arginine, or D-arginine were administered in rats with gastric mucosal lesion induced by pure ethanol. Gastric mucosal blood flow (GMBF), pH of the gastric juice and gastric mucosal NO 2 /NO 3 ratio were determined and the changes of ulcer index and the severity of tissue necrosis and neutrophil infiltration observed. RESULTS: The ulcer index of rats with omeprazole treatment was much lower than that of the control group (P<0.01) with lesser degree of tissue necrosis and neutrophil infiltration (P<0.01). The protective effect of omeprazole was significantly inhibited by prior administration of L-NAME that, however, was antagonized by prior administration of L-arginine, but not D-arginine. Intravenous omeprazole administration obviously increased GMBF and gastric mucosal NO-2 /NO 3 ratio, and such effect, apart from its action against secretion, could be counteracted by pretreatment with L-NAME. CONCLUSION: Omeprazole can exert important protection against gastric mucosal lesion in rats mediated by nitric oxide, and the action of omeprazole against gastric acid secretion contributes little to the protective effect.
Key concepts: Omeprazole, Nitric oxide, Gastric mucosa, Ulcer index, Arginine, Lesion, Gastric acid, Gastroenterology